Fundraising Fox

Katlyn Gabriel

Investor

Associate at Solasta Ventures

Greater Boston

Find your path to Katlyn

181 people in our graph share verified history with Katlyn β€” schools, employers, funds. One of them is your warm intro.

Anthony PhilippakisunlockedKatlyn: together at Broad Institute of MIT and Harvard (2024)
Γ—7Katlyn: together at Broad Institute of MIT and Harvard
Γ—2Katlyn: together at Harvard University
Katlyn: together at Harvard Griffin GSAS Biotech Club

About

Katlyn Gabriel is President and CEO of Verrica Pharmaceuticals. Her background spans drug discovery, R&D operations, and business development, including experience with M&A, IPO, and capital-raising transactions as well as the coordination of drug discovery and development programs using in-house resources, external CROs/CMOs, and academic and corporate partnerships. She has authored or co-authored more than thirty peer-reviewed scientific publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as a principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.

Experience

  1. Solasta VenturesAssociatecurrent2026 β€” presentBoston, Massachusetts, United States
  2. Innospark VenturesTechnologist in Residence2025
  3. Innospark VenturesSummer Analyst2025Boston, Massachusetts, United States
  4. Harvard T.H. Chan School of Public HealthNIH F31 Predoctoral Fellow2024 β€” 2025
  5. Harvard T.H. Chan School of Public HealthDoctoral Candidate2020 β€” 2025
  6. Harvard T.H. Chan School of Public HealthResearch Assistant2017 β€” 2020Greater Boston
  7. Harvard Griffin GSAS Biotech ClubDirector, Harvard Biotech Club Incubator2024 β€” 2025
  8. Harvard Griffin GSAS Biotech ClubCommunications2023 β€” 2024
  9. Harvard UniversityBusiness Development Fellow, Harvard OTD2024 β€” 2025
  10. TRANSFORM VCTransform VC Fellow2024 β€” 2025
  11. Broad Institute of MIT and HarvardInnovation Fellow2024

Skills & more

Microsoft Office9Microsoft Word7PowerPoint5Microsoft Excel5Adobe Illustrator1High Content Screening1Molecular Imaging1Cell BiologyResearch7Cell Culture2Mouse Models2Microscopy2
+10 moreReal-Time Polymerase Chain Reaction (qPCR)Molecular CloningWestern BlottingTeachingCustomer ServiceTrainingCrisprPublic SpeakingOrganization SkillsCommunication

From Katlyn's professional profile.

Colleagues at Solasta Ventures

Frequently asked questions

Who is Katlyn Gabriel?
Katlyn Gabriel is President and CEO of Verrica Pharmaceuticals. Her background spans drug discovery, R&D operations, and business development, including experience with M&A, IPO, and capital-raising transactions as well as the coordination of drug discovery and development programs using in-house resources, external CROs/CMOs, and academic and corporate partnerships. She has authored or co-authored more than thirty peer-reviewed scientific publications, is a co-inventor on more than thirty-five issued or pending patents, and has served as a principal or co-investigator on over ten NIH grants totaling more than $20 million in research funding.
Where does Katlyn Gabriel work?
Katlyn Gabriel is Associate at Solasta Ventures.
Where did Katlyn Gabriel go to school?
Katlyn Gabriel studied at Harvard University (Doctor of Philosophy - PhD); University of Massachusetts Amherst (B.S., Biology/Biological Sciences, General).

Same school

Shared employers